Article Versions Notes

Oliver J, Onieva JL, Garrido-Barros M, Cobo-Dols M, Martínez-Gálvez B, García-Pelícano AI, Dubbelman J, Benítez JC, Martín JZ, Cantero A, et al. Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade. Cancers. 2023; 15(13):3357. https://doi.org/10.3390/cancers15133357

Oliver, Javier, Juan Luis Onieva, María Garrido-Barros, Manuel Cobo-Dols, Beatriz Martínez-Gálvez, Ana Isabel García-Pelícano, Jaime Dubbelman, José Carlos Benítez, Juan Zafra Martín, Alejandra Cantero, and et al. 2023. "Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade" Cancers 15, no. 13: 3357. https://doi.org/10.3390/cancers15133357

Oliver, J., Onieva, J. L., Garrido-Barros, M., Cobo-Dols, M., Martínez-Gálvez, B., García-Pelícano, A. I., Dubbelman, J., Benítez, J. C., Martín, J. Z., Cantero, A., Pérez-Ruiz, E., Rueda-Domínguez, A., & Barragán, I. (2023). Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade. Cancers, 15(13), 3357. https://doi.org/10.3390/cancers15133357